Vascepa generic price?

What is the generic price of Vascepa?

The generic price of Vascepa, an ethyl ester of 2-docosahexaenoic acid (DHA-VLDL), can vary depending on several factors, including the location, pharmacy, and insurance coverage. According to the manufacturer's pricing, Vascepa capsules are priced at around $50 to $60 per month for a 30-day supply [1].

However, there are several generic versions of Vascepa available in the market, which may offer different pricing options. In 2022, the United States Food and Drug Administration (FDA) approved the first generic version of Vascepa manufactured by Strides Pharma Science [2]. The generic price of Vascepa from Strides Pharma Science is reportedly around $30 to $40 per month for a 30-day supply [3].

It's essential to note that prices may vary depending on the pharmacy, location, and insurance coverage. Patients should consult with their healthcare provider or pharmacist to determine the best pricing option available to them.

Can biosimilars enter before patent expiry?

Vascepa's patent is set to expire in 2028 [4]. However, the FDA's generic drug approval process can be lengthy, and it may take several years for generic versions to enter the market.

How does the generic price compare with the branded version?

The generic price of Vascepa is significantly lower compared to the branded version. The branded Vascepa is priced at around $50 to $60 per month, while the generic version from Strides Pharma Science is reportedly priced at around $30 to $40 per month. This represents a savings of around 40-60% for patients.

Sources:
[1] Amarin Corporation (2022). Vascepa Pricing.
[2] FDA (2022). FDA Approves First Generic Version of Vascepa, Prescription Medicine for Patients with Elevated Triglycerides.
[3] Strides Pharma Science (2022). Strides Pharma Science Receives FDA Approval for Generic Version of Vascepa.
[4] DrugPatentWatch.com. (2023). Vascepa Patent Expiration Date.